Pan-cancer analysis indicated that NPLOC4 was highly expressed in most types of cancer, including clear cell renal cell carcinoma, bladder urothelial carcinoma, and papillary renal cell carcinoma (Fig. 1a). This evidence concerns the gene NPLOC4 and bladder transitional cell carcinoma.